Li Xianxin
PhD in Medicine- Chief Physician
- Professor
Specialty: Urology
Languages: English · Mandarin
Conditions Treated
- Prostate Cancer
- Bladder Cancer
- Kidney Cancer
- Benign Prostatic Hyperplasia
- Adrenal Disorders
- Male Infertility
- Sexual Dysfunction
Procedures
- Radical Prostatectomy
- Radical Cystectomy
- Ileal Neobladder Reconstruction
- Minimally Invasive Prostate Surgery
- Adrenal Surgery
- Urologic Cancer Surgery
- Male Infertility Treatment
- - Sexual Dysfunction Treatment 其中 Urogenital Malignancies 属于总标签，已经填写前列腺
Expertise
Professor Xianxin Li has three decades of experience in urology, urologic oncology and andrology. His clinical strengths include the early diagnosis and surgical treatment of urogenital malignancies, minimally invasive management of benign prostatic hyperplasia, adrenal surgery and comprehensive care for male infertility and sexual dysfunction. He is experienced in complex procedures such as radical prostatectomy and radical cystectomy with ileal neobladder reconstruction. Advanced clinical and research training at the University of California, San Francisco and Osaka University supports his emphasis on precise diagnosis, minimally invasive surgery, organ function and individualized treatment planning.、
Experience
- Chair, Andrology Branch, Shenzhen Medical Association
- Vice Chair, Andrology Branch, Guangdong Medical Association
- Vice Chair, Men's Health Management Branch, Guangdong Health Management Association
- Member, Urogenital Oncology Committee, Guangdong Anti-Cancer Association
Research & Publications
- FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer Cell Death & Disease, 2021.
- miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Cellular Physiology and Biochemistry, 2018.
- Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer Oncotarget, 2016.
- Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma Nature Genetics, 2012.
- Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events PLOS ONE, 2011.
- Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma PLOS ONE, 2010.
Locations
Shenzhen Qianhai Taikang Hospital
No. 3099 Menghai Avenue, Nanshan Subdistrict, Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone, Shenzhen, Guangdong Province, China Get directions